Company Search:
Advanced Search
Sponsored Links
Galapagos - ADR Company Snapshot
Galapagos - ADR operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Galapagos - ADR with three other companies in this sector in the United States: Reata Pharmaceuticals Inc (2015 sales of $50.32 million of which 100% was Pharmaceutical), Aduro Biotech Inc ($72.98 million ), and Recro Pharma Inc ($51.95 million of which 100% was Pharmaceutical).

Sales Analysis. Galapagos - ADR reported sales of $66.82 million for the year ending December of 2015. This represents a sharp decrease of 43.8% versus 2014, when the company's sales were $118.86 million.
  Stock Performance Chart for Galapagos - ADR
  Stock Data: Recent Stock Performance:
  Current Price (2/17/2017): 69.80
(Figures in U.S. Dollars)
1 Week 1.4%   13 Weeks 5.8%  
4 Weeks 16.8%   52 Weeks 58.0%  
Galapagos - ADR Key Data:
  Ticker: GLPG Country: United States
  Exchanges: NAS OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 66,815,608
(Year Ending Jan 2016).
Employees: 435
  Currency: U.S. Dollars Market Cap: 3,222,653,994
  Fiscal Yr Ends: December Shares Outstanding: 46,169,828
  Share Type: Action Ordinaries Closely Held Shares: 9,104,986
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.